TVTX FY 2014 Earnings — Travere Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

TVTXTravere Therapeutics, Inc.

$3B

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$28M

Gross Profit

$28M98.0% margin

Operating Income

-$80M-283.0% margin

Net Income

-$111M-393.4% margin

EPS (Diluted)

$-4.43

Cash Flow

Operating Cash Flow

-$46M

Free Cash Flow

-$50M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$135M

Total Liabilities

$173M

Stockholders' Equity

-$37M

Cash & Equivalents

$18M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$28M	$0	—
Gross Profit	$28M	$0	—
Operating Income	-$80M	-$24M	-232.9%
Net Income	-$111M	-$34M	-228.0%